|
Market Cap (17-May) $780,594,112 (160th) |
Close (30-Jun) $3.18 |
Volume (30-Jun) 1,248,327 |
Shortsold (5-May) 19,848,665 (2.73%) (93rd) |
|
52w High $1.36 |
52w Low $0.85 |
P/E 97.09 |
EPS -0.96 |
HLS released this announcement to the ASX on 23 May 2023, 9:09. The announcement is marked as price sensitive, and is 1 page(s) in length and 142.59kb in size.
You can view all announcements from HLS and see how they appear on a price chart on the announcements page.
At the date of this announcement, HLS was 1.469% short sold according to ASIC data. It was ranked the 166th most shorted stock on the ASX. It is now ranked as the 93rd most shorted stock on the ASX with 2.733% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from HLS | |
|---|---|
| Notification regarding unquoted securities - HLS | 28 June 2023, 9:31 |
| Change in substantial holding | 2 June 2023, 15:00 |
| Change of Director's Interest Notice | 1 June 2023, 14:03 |
| Directors' Statement re Takeover | 23 May 2023, 9:09 |
| ACL: Response to Healius' Target's Statement | 22 May 2023, 9:55 |
| ACL: Second Supplementary Bidder's Statement | 22 May 2023, 9:41 |
| Appointment of Group Executive, Healius Pathology | 11 May 2023, 9:40 |
You must be logged in to post a reply.
